Literature DB >> 10582732

Clinical aspects, epidemiology, and prognosis of atopic dermatitis.

B Wüthrich1.   

Abstract

OBJECTIVE: This review article examines the clinical aspects, epidemiology, and prognosis of atopic dermatitis. DATA SOURCES: These are studies and review articles from textbooks of dermatitis and allergy in general, as well as more recent epidemiologic surveys published in specialist journals of allergy and dermatology. STUDY SELECTION: Included studies meet the criteria of being a survey of the prevalence of atopic dermatitis published recently in a respected peer-reviewed journal. Particular emphasis is placed on those that examine both the prevalence of the problem and significant causative and associated factors.
RESULTS: Atopic dermatitis is frequently a severe illness that develops in early infancy. It can persist beyond the childhood years and is often found in association with significant respiratory complications. The exact pathogenesis is unclear but it appears that it has a complex immunologic origin. Early surveys lack the methodologic refinements of more recent data from the mid-1990s, including the SCARPOL study. Collectively, these point to a high current prevalence rate of 10% to 15%, a figure that has risen steadily in the preceding decades. The most common associations of atopic dermatitis are a risk of developing respiratory disorders, such as allergic rhinitis and asthma (40% to 60%), and a persistence rate after puberty (40% to 60%), which is indeed much higher than previously suspected.
CONCLUSIONS: A clear recognition of the various disease subgroups along with intervention studies that evaluate reduction of risk are needed before more precise treatment strategies can be devised.

Entities:  

Mesh:

Year:  1999        PMID: 10582732     DOI: 10.1016/S1081-1206(10)62852-9

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  22 in total

1.  Exploring the origins of asthma: Lessons from twin studies.

Authors:  Simon Francis Thomsen
Journal:  Eur Clin Respir J       Date:  2014-09-01

2.  Predicting eczema severity beyond childhood.

Authors:  Kam Lun Hon; Yin-Ching K Tsang; Terence Chuen W Poon; Nga Hin Pong; Matthew Kwan; Shirley Lau; Yuen-Chun Chiu; Hin-Hei Wong; Ting-Fan Leung
Journal:  World J Pediatr       Date:  2015-12-18       Impact factor: 2.764

3.  Analysis of circulating gammadelta T cells in children affected by IgE-associated and non-IgE-associated allergic atopic eczema/dermatitis syndrome.

Authors:  C Cairo; E Arabito; F Landi; A Casati; E Brunetti; G Mancino; E Galli
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

Review 4.  What is intrinsic atopic dermatitis?

Authors:  Anne-Marie Roguedas-Contios; Laurent Misery
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

5.  Do children really outgrow their eczema, or is there more than one eczema?

Authors:  Katrina Abuabara; David J Margolis
Journal:  J Allergy Clin Immunol       Date:  2013-10-04       Impact factor: 10.793

6.  Asthma in patients with atopic dermatitis.

Authors:  Z Pourpak; H Mozaffari; M Gharagozlou; Z Daneshmandi; M Moin
Journal:  Indian J Pediatr       Date:  2008-02       Impact factor: 1.967

Review 7.  [Atopy and asthma].

Authors:  E von Mutius
Journal:  Internist (Berl)       Date:  2008-11       Impact factor: 0.743

8.  Persistence of mild to moderate atopic dermatitis.

Authors:  Jacob S Margolis; Katrina Abuabara; Warren Bilker; Ole Hoffstad; David J Margolis
Journal:  JAMA Dermatol       Date:  2014-06       Impact factor: 10.282

9.  Retrospective analysis of the natural history of atopic dermatitis occurring in the first year of life in Korean children.

Authors:  Younghee Chung; Jung Hyun Kwon; Jihyun Kim; Youngshin Han; Sang-Il Lee; Kangmo Ahn
Journal:  J Korean Med Sci       Date:  2012-06-29       Impact factor: 2.153

10.  Climatic factors are associated with childhood eczema prevalence in the United States.

Authors:  Jonathan I Silverberg; Jon Hanifin; Eric L Simpson
Journal:  J Invest Dermatol       Date:  2013-01-18       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.